Investigating Dynamic Interactions in Distributed Cognitive Control Networks
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05927974 |
Recruitment Status :
Recruiting
First Posted : July 3, 2023
Last Update Posted : April 26, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Cognitive Impairment Dementia ADD Depression | Diagnostic Test: Passive testing Diagnostic Test: Active testing |
Routine intracranial monitoring (ICM) surgery involves placement of several (10-20) electrodes into the brain through a small opening to a target structure. Participants have been deemed a surgical candidate for this procedure, and detailed discussion of the procedure will occur as part of the surgical consent. The Investigators may place sensors (stickers) to monitor participant's arm/hand movements and brain activity. Sensors may be placed on participant's scalp and/or arms and legs. The Investigators may place a device on participant's wrist or finger to measure position (accelerometer). The Investigators may perform voice recordings, eye movement tracking, and motion capture recordings to obtain measures of how stimulation affects speech and other movements. These are performed without any attachment of devices.
Cognitive tasks: Multiple cognitive tasks may be used and will be decided upon based on the clinical symptoms, exam, or comorbidities. These may include Go/No-go, Simon/Stroop task, Stop-signal task, language tasks, Tower of London, gambling task, maze navigation, choice-reaction time, delay tasks, and attention tasks.
Cortico-cortical evoked potentials and Patterned Stimulation: Stimulus pulses at precise time intervals and or various patterns will be delivered across adjacent electrode contacts at a series of electrode sites while simultaneously recording neural activity at other electrodes. This does not require any activity from participant.
Tasks will be administered via computer monitor positioned in front of the you. This will be connected to a recording computer. Participant will respond via keyboard, mouse, or response button.
Study Type : | Observational |
Estimated Enrollment : | 30 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Investigating Dynamic Interactions in Distributed Cognitive Control Networks |
Actual Study Start Date : | March 27, 2023 |
Estimated Primary Completion Date : | March 27, 2027 |
Estimated Study Completion Date : | January 1, 2028 |
Group/Cohort | Intervention/treatment |
---|---|
ICM Patients
Epillipsey Patients undergoing routine intracranial EEG monitoring for epilepsy.
|
Diagnostic Test: Passive testing
Passive testing includes baseline recordings or behavioral tasks without stimulation. Examples include language tasks, cognitive, and motor tasks. Passive testing typically takes 30-60 minutes and does not require presence of an epileptologist as the tasks are of minimal or no risk. Diagnostic Test: Active testing Active testing includes any study activity in which stimulation occurs. The most frequent paradigm consists of delivering small amounts of electrical stimulation through the implanted grid/strip/depth electrodes. This will be either continuous stimulation or patterned stimulation such as intermittent theta-burst . Stimulation will range between 1-8 mAmp. The duration of these pulses will last between 2-5 seconds. Subjects may be asked to rest quietly or to perform behavioral tasks during stimulation. Since there is a risk of evoking seizure activity with active testing, presence of an epileptologist is required. Active testing will only occur once the PI/staff has communicated with the epileptologist regarding safety, feasibility, and timing of active testing. Active testing will typically take 60-90 minutes and is only performed once patients are back on their anti-seizure medications. |
- Go/No-go [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Simon/Stroop task [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Stop-signal task [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Language task [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Tower of London [ Time Frame: Post-op Day Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Gambling task [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Maze navigation [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Choice-reaction time [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Delay task [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Attention task [ Time Frame: Post-op through study completion, an average of 7 days. ]Cognitive tasks given will be decided upon based on the clinical symptoms, exam, or comorbidities. Tasks will be administered via computer monitor positioned in front of the subject. This will be connected to a recording computer. Participants will respond via keyboard, mouse, or response button.
- Cortico-cortical evoked potentials [ Time Frame: Post-op through study completion, an average of 7 days. ]Stimulus pulses at precise time intervals will be delivered across adjacent electrode contacts at a series of electrode sites while simultaneously recording neural activity at other electrodes.
- Patterned Stimulation [ Time Frame: Post-op through study completion, an average of 7 days. ]Stimulus pulses at various patterns will be delivered across adjacent electrode contacts at a series of electrode sites while simultaneously recording neural activity at other electrodes.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Eligible for surgery based on multi-disciplinary consensus review
- Have a diagnosis of medically-refractory epilepsy
- A minimum of 18 years of age
- Willingness to participate in the paradigms described in the protocol
Exclusion Criteria:
- Inability to provide full and informed consent
- Age younger than 18
- Are not physically able to participate in study-related activities
- Major medical or surgical complication
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05927974
Contact: Jessica N Bentley, MD | 2059347170 | jbentley@uabmc.edu |
United States, Alabama | |
University of Alabama at Birmingham | Recruiting |
Birmingham, Alabama, United States, 35233 | |
Contact: Jessica N Bentley, MD 205-934-7170 jbentley@uabmc.edu |
Principal Investigator: | Jessica N Bentley, MD | The University of Alabama at Birmingham |
Responsible Party: | J. Nicole Bentley, Assistant Professor, University of Alabama at Birmingham |
ClinicalTrials.gov Identifier: | NCT05927974 |
Other Study ID Numbers: |
IRB-300010350 UAB ( Other Identifier: UAB ) |
First Posted: | July 3, 2023 Key Record Dates |
Last Update Posted: | April 26, 2024 |
Last Verified: | April 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Cognitive tasks Epilepsy Intracranial EEG |
Dementia Cognitive Dysfunction Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Neurocognitive Disorders Mental Disorders Cognition Disorders |